The osteo-hepatic axis: a review of bone disease, insulin-like growth factor-1, and fracture risk in fatty liver disease
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) and alcoholic fatty liver disease (AFLD) represent emerging global health burdens with significant extra-hepatic complications. Among these, metabolic bone disease, particularly osteoporosis, has gained recognition as a major determinant of patient morbidity and quality of life. This narrative review synthesizes current evidence on the pathophysiological interplay between fatty liver diseases and bone health, with special emphasis on insulin-like growth factor-1 (IGF-1) dysregulation and bone mineral metabolism. The liver serves as the primary source of circulating IGF-1 and is crucial for vitamin D metabolism. In MASLD and AFLD, hepatocellular injury leads to IGF-1 deficiency, which impairs osteoblast function and bone formation. Concurrently, vitamin D deficiency and secondary hyperparathyroidism promote increased bone resorption. Chronic inflammation, characterized by elevated cytokines like TNF-α and IL-6, further exacerbates bone loss through the RANKL/OPG pathway. In AFLD, additional direct toxic effects of alcohol on osteoblasts compound the problem. Clinical studies consistently demonstrate reduced bone mineral density and increased fracture risk in these populations. Despite this evidence, standardized screening protocols and management guidelines for bone disease in non-cirrhotic fatty liver disease patients are lacking. This review highlights the critical need for integrated care models that address…
Read the paper
Related studies
- Effectiveness of Bisphosphonates and Denosumab on Risk of Vertebral Fractures in Prostate Cancer Patients Under Androgen Deprivation Therapies: A Real-World Prospective Study
- Osteoporosis-related fractures after spinal cord injury: a retrospective study from Brazil
- Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men
- Lack of Association between Vitamin D Insufficiency and Cardiovascular or Fracture Risk: A UK Biobank Study
- Muscle strength and body composition are clinical indicators of osteoporosis
- Incidence of bone protection and associated fragility injuries in patients with proximal femur fractures
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.